DrugMar 19, 2025
Johnson, S C and Son Kids by babyganics SPF 50 totally tropical recall — FDA D-0275-2025
Chemical Contamination
Class IIFDA: OngoingJohnson, S C and Son, Inc
Monthly breakdown
2025 recalls by month
Select a month to review the recall records reported during that period.
December 2025101 records · 3 categoriesNovember 202596 records · 3 categoriesOctober 2025133 records · 3 categoriesSeptember 2025116 records · 3 categoriesAugust 202582 records · 3 categoriesJuly 202537 records · 2 categoriesJune 202525 records · 2 categoriesMay 202553 records · 2 categoriesApril 202542 records · 2 categoriesMarch 202532 records · 2 categoriesFebruary 202527 records · 2 categoriesJanuary 202526 records · 2 categories
2025 recalls — page 30
Records are ordered by the best available source date.
DrugMar 19, 2025
POTASSIUM CHLORIDE Inj., 20 mEq total in 100 mL flexible container 24 x case, 200 mEq/L recall — FDA D-0267-2025
Labeling: Label Error on Declared Strength. Cases labeled POTASSIUM CHLORIDE 20 mEq, may contain flexible containers with overwrap mislabeled as 10 mEq. The correct dosage strength of 20…
Class IFDA: OngoingICU Medical, Inc.
DrugMar 19, 2025
Central Admixture Pharmacy Services PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 recall — FDA D-0272-2025
Presence of Particulate Matter
Class IFDA: OngoingCentral Admixture Pharmacy Services, Inc.
DrugMar 19, 2025
POTASSIUM CHLORIDE Inj., 10 mEq total in 100 mL, 100 mEq/L flexible container recall — FDA D-0268-2025
Labeling: Label Error on Declared Strength. Overwrap labeled as Potassium Chloride Inj 10 mEq may contain flexible containers of Potassium Chloride Inj 20 mEq
Class IFDA: OngoingICU Medical, Inc.
DrugMar 19, 2025
Johnson, S C and Son Kids by babyganics SPF 50 mineral sunscreen totally tropical recall — FDA D-0276-2025
Chemical Contamination
Class IIFDA: OngoingJohnson, S C and Son, Inc
DrugMar 19, 2025
Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles recall — FDA D-0258-2025
Presence of foreign tablets/capsules
Class IIIFDA: CompletedKowa Pharmaceuticals America
DrugMar 19, 2025
Aspen Biopharma Labs Pvt Finasteride NDC# 82187-1003-1 Container Description: The product recall — FDA D-0262-2025
CGMP Deviations
Class IIFDA: OngoingAspen Biopharma Labs Pvt., Ltd.
DrugMar 19, 2025
Chattem Unisom, SleepMelts, Diphenhydramine HCl tablets, 25 mg, Nighttime Sleep-Aid, 4 x 8 recall — FDA D-0266-2025
CGMP Deviations: Nitrosamine Drug Substance Related Issue impurity above the daily acceptable intake limit defined by the Food and Drug Administration.
Class IIFDA: OngoingChattem Inc
VehicleMar 14, 2025
F-150 control module (tcm/pcm/tecm) recall — NHTSA campaign 25V169000
Ford Motor Company (Ford) is recalling certain 2021 F-150 vehicles previously repaired incorrectly under recall number 22V-188. The Diagnostic Trouble Code (DTC) for low transmission fluid…
control module (tcm/pcm/tecm)Ford Motor Company
VehicleMar 14, 2025
Ford valves/valve body recall — NHTSA campaign 25V164000
Ford Motor Company (Ford) is recalling certain 2024-2025 F-150, Bronco, 2024 Ranger, 2025 Mustang, Explorer, and Aviator vehicles. The transmission valve body may have been machined…
valves/valve bodyFord Motor Company
VehicleMar 12, 2025
BMW hoses, lines/piping, and fittings recall — NHTSA campaign 25V154000
BMW of North America, LLC (BMW) is recalling certain 2025 X3 30 xDrive and X3 M50 xDrive vehicles. The rear brake hoses may leak, causing a loss of rear brake function, and a loss of the…
hoses, lines/piping, and fittingsBMW of North America, LLC
DrugMar 12, 2025
Nelarabine Injection, 250mg/50mL, (5mg/mL) recall — FDA D-0255-2025
Failed Impurities/Degradation Specifications
Class IIFDA: OngoingZydus Pharmaceuticals (USA) Inc
DrugMar 12, 2025
Safecor Health Simethicone 20 mg per 0.3 mL Oral Syringe, Delivers: 0.3 mL, Oral Drops, Mfg recall — FDA D-0251-2025
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class IIFDA: OngoingSafecor Health, LLC
DrugMar 12, 2025
Safecor Health Morphine Sulfate 5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral recall — FDA D-0254-2025
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class IIFDA: OngoingSafecor Health, LLC
DrugMar 12, 2025
Nelarabine Injection, 250mg/50mL, (5mg/mL) recall — FDA D-0256-2025
Failed Impurities/Degradation Specifications
Class IIFDA: OngoingZydus Pharmaceuticals (USA) Inc
DrugMar 12, 2025
Safecor Health Ferrous Sulfate 7.5 mg Iron/0.5 mL Oral Syringe, Delivers: 0.5 mL, Iron recall — FDA D-0252-2025
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class IIFDA: OngoingSafecor Health, LLC
DrugMar 12, 2025
Safecor Health Lorazepam 0.5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral recall — FDA D-0253-2025
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class IIFDA: OngoingSafecor Health, LLC
DrugMar 12, 2025
Safecor Health Ergocalciferol - Vitamin D Supplement - 10 mcg (400 Units) per 0.05 mL Oral recall — FDA D-0250-2025
Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.
Class IIFDA: OngoingSafecor Health, LLC
DrugMar 5, 2025
Wuxi Medical lnstrument Factory Co ViaMed Alcohol Prep Pads, For External Use Only, 70% recall — FDA D-0247-2025
Lack of assurance of sterility and cGMP deviations observed at the manufacturing site.
Class IIFDA: OngoingWuxi Medical lnstrument Factory Co., Ltd.
DrugMar 5, 2025
Turbare Manufacturing Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection recall — FDA D-0248-2025
Lack of Assurance of Sterility: due to a quality control process deviation
Class IIFDA: CompletedTurbare Manufacturing
DrugMar 5, 2025
Padagis US Estradiol Gel, 0.1%, 0.25 mg/g, 30 packets per carton recall — FDA D-0246-2025
Defective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.
Class IIFDA: CompletedPadagis US LLC
VehicleFeb 28, 2025
Ford integrated trailer brake control recall — NHTSA campaign 25V132000
Ford Motor Company (Ford) is recalling certain 2021-2022 F-150, 2022 Maverick, Expedition, Lincoln Navigator, F-250, F-350, F-450, and F-550 vehicles previously repaired incorrectly under…
integrated trailer brake controlFord Motor Company
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 40 mg, 30 capsule bottles recall — FDA D-0241-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugFeb 26, 2025
Atomoxetine Capsules, USP, 10 mg, 30 capsule bottles recall — FDA D-0238-2025
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
About the 2025 recall archive
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.